MARKET

GRFS

GRFS

Grifols S A
NASDAQ
7.10
-0.20
-2.74%
After Hours: 7.10 0 0.00% 16:01 05/09 EDT
OPEN
7.22
PREV CLOSE
7.30
HIGH
7.28
LOW
7.09
VOLUME
1.16M
TURNOVER
--
52 WEEK HIGH
9.96
52 WEEK LOW
5.79
MARKET CAP
4.88B
P/E (TTM)
29.55
1D
5D
1M
3M
1Y
5Y
1D
ADMA's Q1 Earnings and Revenues Miss: Buy, Sell or Hold the Stock?
NASDAQ · 2d ago
Weekly Report: what happened at GRFS last week (0428-0502)?
Weekly Report · 5d ago
Should ADMA Biologics Stock Be in Your Portfolio Pre-Q1 Earnings?
NASDAQ · 05/01 17:22
Weekly Report: what happened at GRFS last week (0421-0425)?
Weekly Report · 04/28 09:25
Bathia and Bacon to leave Probitas leadership roles
Reuters · 04/24 12:20
Grifols: A Market Setback Turns Into Buying Opportunity
Seeking Alpha · 04/23 15:10
White Falcon Capital Q1 2025 Partner's Letter
Seeking Alpha · 04/23 14:50
Weekly Report: what happened at GRFS last week (0414-0418)?
Weekly Report · 04/21 09:25
More
About GRFS
More
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Recently
Symbol
Price
%Change

Webull offers Grifols SA - ADR stock information, including NASDAQ: GRFS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRFS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRFS stock methods without spending real money on the virtual paper trading platform.